Posted Mon, May, 07,2012
Libertas Academica has been using Twitter since February 2010 to benefit readers and authors.
As a reader, by following Translational Oncogenomics on Twitter you will be notified about new articles in your field of expertise, calls for papers, Editorial announcements, and any other important updates for the journal.
We post on Twitter within minutes of a paper being published so Twitter followers are the first people to view new articles.
For authors our Twitter services offer your article even greater visibility. Libertas Academica uses Twitter because it’s visibility and popularity gives us the opportunity to inform thousands of people about new articles published.
Visit the Translational Oncogenomics Twitter feed
What is Twitter?
Twitter is one of the most popular and user-friendly social media sites on the internet.
By following Translational Oncogenomics on Twitter, you can receive e-mail, SMS and website notifications of new articles and other important updates.
We make sure that readers are kept up to date with the latest news and publications for all of our journals, and can reach over 7,000 Twitter subscribers.
See our full list of Twitter services
Posted in: Social Media
News Categories
Wed 19 Jun, 2013
Pharmacotherapies in InsomniaWed 19 Jun, 2013
RNAi Mediated Approaches of Virus ResistanceWed 19 Jun, 2013
Characterization of a Guano ConcretionMy experience with Libertas Academica was very positive from submission to acceptance. There was excellent feedback throughout and excellent help from editorial office of Clinical Medicine Insights: Therapeutics. The author interface was user-friendly and effective.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
Facebook Google+ Twitter
Pinterest Tumblr YouTube